1. Academic Validation
  2. USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy

USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy

  • Cell Signal. 2024 Feb 1:117:111070. doi: 10.1016/j.cellsig.2024.111070.
Dongchen Wang 1 Zihao Jiang 1 Junyan Kan 1 Xiaomin Jiang 1 Chang Pan 1 Shijie You 2 Ruirui Chang 1 Juan Zhang 1 Hongfeng Yang 1 Linlin Zhu 3 Yue Gu 4
Affiliations

Affiliations

  • 1 Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • 2 Dushu Lake Hospital Affiliated to Soochow University (Suzhou Dushu Lake Hospital), Suzhou, China.
  • 3 Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: zhulinlin_007@sina.com.
  • 4 Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: guyue_jessica@163.com.
Abstract

Doxorubicin (Dox) is a potent antineoplastic agent, but its use is curtailed by severe cardiotoxicity, known as Dox-induced cardiomyopathy (DIC). The molecular mechanism underlying this cardiotoxicity remains unclear. Our current study investigates the role of Ubiquitin-Specific Protease 36 (USP36), a nucleolar deubiquitinating Enzyme (DUB), in the progression of DIC and its mechanism. We found increased USP36 expression in neonatal rat cardiomyocytes and H9C2 cells exposed to Dox. Silencing USP36 significantly mitigated Dox-induced oxidative stress injury and Apoptosis in vitro. Mechanistically, USP36 upregulation positively correlated with Poly (ADP-ribose) polymerase 1 (PARP1) expression, and its knockdown led to a reduction in PARP1 levels. Further investigation revealed that USP36 could bind to and mediate the deubiquitination of PARP1, thereby increasing its protein stability in cardiomyocytes upon Dox exposure. Moreover, overexpression of wild-type (WT) USP36 plasmid, but not its catalytically inactive mutant (C131A), stabilized PARP1 in HEK293T cells. We also established a DIC model in mice and observed significant upregulation of USP36 in the heart. Cardiac knockdown of USP36 in mice using a type 9 recombinant adeno-associated virus (rAAV9)-shUSP36 significantly preserved cardiac function after Dox treatment and protected against Dox-induced structural changes within the myocardium. In conclusion, these findings suggest that Dox promotes DIC progression by activating USP36-mediated PARP1 deubiquitination. This novel USP36/PARP1 axis may play a significant regulatory role in the pathogenesis of DIC.

Keywords

Apoptosis; Dox-induced cardiomyopathy; Oxidative stress; Poly (ADP-ribose) polymerase 1; Ubiquitin-Specific Protease 36.

Figures
Products
Inhibitors & Agonists
Other Products